N1c colon cancer and the use of adjuvant chemotherapy: a current audit of the National Cancer Database.
Hillary L SimonThais Reif de PaulaZachary A SpigelDeborah Susan KellerPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2020)
In the USA, AC is underutilized in N1c colon cancer despite significantly improved OS. Socioeconomic and procedural factors associated with AC were identified, highlighting disparities in AC use and opportunities to improve oncological outcomes and survival.